137 related articles for article (PubMed ID: 12407127)
1. Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers.
Burkhardt O; Borner K; von der Höh N; Köppe P; Pletz MW; Nord CE; Lode H
J Antimicrob Chemother; 2002 Nov; 50(5):707-12. PubMed ID: 12407127
[TBL] [Abstract][Full Text] [Related]
2. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
4. Age and sex effects on the pharmacokinetics of linezolid.
Sisson TL; Jungbluth GL; Hopkins NK
Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
[TBL] [Abstract][Full Text] [Related]
5. Ocular penetration of linezolid after oral administration in rabbits.
Saleh M; Lefevre S; Bourcier T; Prevost G; Gaucher D; Speeg-Schatz C; Jehl F
J Ocul Pharmacol Ther; 2011 Jun; 27(3):243-6. PubMed ID: 21510740
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
[TBL] [Abstract][Full Text] [Related]
10. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
[TBL] [Abstract][Full Text] [Related]
13. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
14. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
Bosso JA; Flume PA; Gray SL
Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
[TBL] [Abstract][Full Text] [Related]
15. Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
Hamilton R; Thai XC; Ameri D; Pai MP
J Antimicrob Chemother; 2013 Mar; 68(3):666-73. PubMed ID: 23160755
[TBL] [Abstract][Full Text] [Related]
16. Linezolid absolute bioavailability and the effect of food on oral bioavailability.
Welshman IR; Sisson TA; Jungbluth GL; Stalker DJ; Hopkins NK
Biopharm Drug Dispos; 2001 Apr; 22(3):91-7. PubMed ID: 11745911
[TBL] [Abstract][Full Text] [Related]
17. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
Stalker DJ; Jungbluth GL
Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
[TBL] [Abstract][Full Text] [Related]
19. Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.
Cai Y; Chai D; Falagas ME; Karageorgopoulos DE; Wang R; Bai N; Liang B
Expert Opin Investig Drugs; 2013 Mar; 22(3):309-15. PubMed ID: 23360474
[TBL] [Abstract][Full Text] [Related]
20. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
